Parallel Advisors »

Design Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $642 102 6.30
2023-03-31 $289 50 5.78

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Amazon.com Stock (AMZN)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Ishares Core Msci Eafe Etf Etf (IEFA)
Avantis International Equity Etf Etf (AVDE)

View all positions for Parallel Advisors

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Point72 Asset Management
BlackRock
Frazier Life Sciences Management
Tang Capital Management
Baker Bros. Advisors
Almitas Capital
Vanguard Group
Driehaus Capital Management
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics